Insider Stock Trading History of Elms Steve


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Elms Steve since year 2005. The trader's CIK number is 1250195. At the time of this reporting, Elms Steve is the of Esperion Therapeutics, Inc. . (stock ticker symbol ESPR). See this page for all insider trading activities at Esperion Therapeutics, Inc. .

Note that in the past ELMS STEVE also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Elms Steve since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-04-23 ESPR Esperion Therapeutics, Inc. Sale 150,000 109.10 16,365,000
2015-04-24 ESPR Esperion Therapeutics, Inc. Sale 67,469 107.05 7,222,556
2014-08-12 TTOO T2 Biosystems, Inc. Buy 454,545 11.00 4,999,995
2014-08-06 LOXO Loxo Oncology, Inc. Buy 413,077 13.00 5,370,001
2014-04-21 TRXC Cellular Technical Services Co Inc Buy 1,037,767 4.00 4,151,068
2014-03-21 DRTX Durata Therapeutics, Inc. Sale 2,649 15.57 41,255
2014-03-20 DRTX Durata Therapeutics, Inc. Sale 98,000 15.74 1,542,618
2013-11-14 ZLTQ Zeltiq Aesthetics Inc Sale 575,000 12.22 7,026,500
2013-10-22 ADMA Adma Biologics, Inc. Buy 411,765 8.50 3,500,002
2013-07-01 ESPR Esperion Therapeutics, Inc. Buy 238,119 14.00 3,333,666
2013-05-21 AMBI Ambit Biosciences Corp Buy 423,635 8.00 3,389,080
2012-07-24 DRTX Durata Therapeutics, Inc. Buy 1,111,111 9.00 9,999,999
2012-02-07 CEMP Cempra, Inc. Buy 1,213,663 6.00 7,281,978
2011-10-24 ZLTQ Zeltiq Aesthetics Inc Buy 769,231 13.00 10,000,003
2010-03-10 MAPP Map Pharmaceuticals, Inc. Sale 2,090 16.15 33,753

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Elms Steve ( of Esperion Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.